AAE581

DRUG2 trials

Sponsors

Novartis Pharmaceuticals

Conditions

Osteoporosis

Phase 2

Safety and Efficacy of AAE581 in Postmenopausal Women With Osteoporosis

CompletedNCT00100607

Novartis PharmaceuticalsOsteoporosis

Start: 2004-02-29End: 2005-09-30Updated: 2012-05-08

Efficacy and Safety of AAE581 in Postmenopausal Women With Osteopenia/Osteoporosis.

CompletedNCT00170911

Novartis PharmaceuticalsOsteoporosis

Start: 2005-03-31Target: 160Updated: 2011-11-02